FDA Administration - Search News

FDA recalls nearly 90,000 bottles of children's ibuprofen

FDA issues urgent, nationwide recall for 85K+ bottles of children’s medicine

More than 89,000 bottles of children’s medication are being recalled after the manufacturer received several complaints that the products contained foreign matter.

· 21h · on MSN

FDA recalls nearly 90,000 bottles of children's ibuprofen over contamination risk

The Telegraph on MSN · 18h

FDA recalls nearly 90,000 bottles of children’s ibuprofen over contamination

· 20h

Nearly 90,000 bottles of children’s liquid pain medication recalled

Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of black specs and other contaminants, according to federal regulators.

· 1d

Recall alert: Nearly 90K bottles of children’s ibuprofen recalled for foreign substance

· 1d

FDA Recalls 90,000 Children's Ibuprofen Bottles Nationwide After Consumers Report Black Particles, Gel Mass

FDA approves higher-dose Wegovy shots

Digest more

· 12h

Fast-track FDA approval brings stronger Wegovy to pharmacies by April

The Food and Drug Administration has approved a higher-dose version of the weight-loss drug Wegovy through a pilot program designed to accelerate drug approvals.

ConsumerAffairs · 1d

FDA approves a higher dose of the weight-loss drug, Wegovy

· 1d

FDA approves new higher-dose version of Wegovy shots

· 1d

FDA Approves New Higher-Dose Version of Wegovy Shots

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off.

· 1d

US FDA approves higher dose of Wegovy

· 1d

Novo Nordisk wins U.S. approval for higher-dose Wegovy

Rhythm's therapy becomes first FDA-approved treatment for brain damage-related obesity

The U. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’ therapy for a ‌rare form of obesity caused by brain damage, making

STAT

FDA’s top infectious disease regulator to depart agency

Adam Sherwat, the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, is leaving the agency.

14d

Trump administration's embattled FDA vaccine chief is leaving again

The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he's departed after controversial decisions involving the review of vaccinations and specialty drugs for rare diseases.

FDA drops proposed rule barring tanning bed use for minors

On Tuesday, the Food and Drug Administration pulled a proposed rule that would have banned anyone under age 18 from using tanning beds.

STAT

Political influence ‘a serious problem’ for FDA under Trump, former commissioner says

What's changed now is that there's a view in this administration that everything is political,” said Robert Califf, former FDA commissioner.

14d

Trump administration’s embattled FDA vaccine chief is leaving for the second time

WASHINGTON (AP) — The Food and Drug Administration’s embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he’s departed after controversial decisions involving the review of vaccinations and specialty drugs for rare diseases.